Showing results (281-290 of 312) with videos related to

Sort By:
Pageof 32
Neurology|February 13, 2002
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PDM Ulivelli, S Rossi, C Lombardi, et al.
Thyroid : Official Journal of the American Thyroid Association|June 1, 1997
Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatmentP Vitti, T Rago, L Chiovato, et al.
La Medicina Del Lavoro|October 26, 2001
[Occupational accidents in temporary work]A Nola, G Cattaneo, A Maiocchi, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 19, 2002
Synthesis, conformation and biological activity of linear and cyclic Thr6-bradykinin analogues containing N-benzylglycine in place of phenylalanineL Biondi, F Filira, M Gobbo, et al.
Neurochemistry International|May 28, 2010
A new ?-helical motif in membrane active peptidesY Kobayashi, A Sato, H Takashima, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|March 25, 2000
Graves' ophthalmopathy and 131I therapyC Marcocci, L Bartalena, M L Tanda, et al.
Clinical Orthopaedics and Related Research|December 1, 1988
Electrical stimulation of human femoral intertrochanteric osteotomies. Double-blind studyG Borsalino, M Bagnacani, E Bettati, et al.
Journal of Clinical Immunology|May 1, 1997
Inverse correlation between IgG-antihinge region and antierythrocyte autoantibody in chronic benign and malignant cold agglutinationP Terness, M Kirschfink, D Navolan, et al.
Clinical Endocrinology|May 3, 2000
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoidsL Bartalena, L Manetti, M L Tanda, et al.
Protein Science : a Publication of the Protein Society|December 14, 1999
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokininV Gigoux, B Maigret, C Escrieut, et al.
Pageof 32